NasdaqGM - Nasdaq Real Time Price USD

Amicus Therapeutics, Inc. (FOLD)

9.69

+0.12

(+1.31%)

As of 2:54 PM EDT. Market Open.

Key Events

Loading Chart for FOLD

9/21 12:03 PM

DELL

Previous Close 9.57
Open 9.57
Bid 9.64 x 100
Ask 9.74 x 100
Day's Range 9.54 - 9.76
52 Week Range 9.02 - 14.57
Volume 847,854
Avg. Volume 3,055,453
Market Cap (intraday) 2.872B
Beta (5Y Monthly) 0.79
PE Ratio (TTM) --
EPS (TTM) -0.49
Earnings Date Aug 6, 2024 - Aug 12, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 17.33

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

517

Full Time Employees

December 31

Fiscal Year Ends

Sector

Industry

Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FOLD

31.68%

S&P 500

11.34%

1-Year Return

FOLD

18.53%

S&P 500

26.69%

3-Year Return

FOLD

8.20%

S&P 500

29.03%

5-Year Return

FOLD

20.86%

S&P 500

85.72%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Amicus Therapeutics, Inc.

9.70

+1.31%

Mkt Cap 2.872B

Industry Biotechnology

ACADIA Pharmaceuticals Inc.

14.90

+0.74%

Mkt Cap 2.462B

Industry Biotechnology

Ultragenyx Pharmaceutical Inc.

41.57

-0.72%

Mkt Cap 3.456B

Industry Biotechnology

Agios Pharmaceuticals, Inc.

33.45

-2.61%

Mkt Cap 1.899B

Industry Biotechnology

Fulcrum Therapeutics, Inc.

7.85

+3.97%

Mkt Cap 487.906M

Industry Biotechnology

Alnylam Pharmaceuticals, Inc.

150.40

+0.67%

Mkt Cap 19.024B

Industry Biotechnology

Ionis Pharmaceuticals, Inc.

38.55

+3.31%

Mkt Cap 5.626B

Industry Biotechnology

PTC Therapeutics, Inc.

39.88

+20.48%

Mkt Cap 3.059B

Industry Biotechnology

Akero Therapeutics, Inc.

20.20

+1.41%

Mkt Cap 1.397B

Industry Biotechnology

SpringWorks Therapeutics, Inc.

42.70

-4.79%

Mkt Cap 3.163B

Industry Biotechnology

Insmed Incorporated

25.21

+1.78%

Mkt Cap 3.746B

Industry Biotechnology

Valuation Measures

As of 5/17/2024

Market Cap

2.83B
Enterprise Value

3.04B
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

6.74
Price/Book (mrq)

21.69
Enterprise Value/Revenue

7.18
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

-34.73%
Return on Assets (ttm)

-5.08%
Return on Equity (ttm)

-126.10%
Revenue (ttm)

423.49M
Net Income Avi to Common (ttm)

-147.07M
Diluted EPS (ttm)

-0.49

Balance Sheet and Cash Flow

Total Cash (mrq)

239.6M
Total Debt/Equity (mrq)

340.10%
Levered Free Cash Flow (ttm)

-37.5M

FOLD does not have Company Insights

PTCT PTC Therapeutics, Inc.

39.88

+20.48%

HALO Halozyme Therapeutics, Inc.

44.74

+0.06%

AGIO Agios Pharmaceuticals, Inc.

33.45

-2.61%

RARE Ultragenyx Pharmaceutical Inc.

41.57

-0.72%

ACAD ACADIA Pharmaceuticals Inc.

14.90

+0.74%

TGTX TG Therapeutics, Inc.

16.38

-0.61%

INSM Insmed Incorporated

25.21

+1.78%

ALNY Alnylam Pharmaceuticals, Inc.

150.40

+0.67%

SRPT Sarepta Therapeutics, Inc.

131.06

-0.24%

CYTK Cytokinetics, Incorporated

60.89

+2.28%

SAGE Sage Therapeutics, Inc.

11.35

-3.03%

CLDX Celldex Therapeutics, Inc.

37.74

-1.23%

FGEN FibroGen, Inc.

1.1950

-0.42%

ESPR Esperion Therapeutics, Inc.

2.4850

+5.31%

SGMO Sangamo Therapeutics, Inc.

0.6178

-4.90%

PBYI Puma Biotechnology, Inc.

4.4600

+8.91%